Under the program Novozymes will buy back B shares for an amount of up to DKK 1,000 million in the period from January 20, 2012, to December 31, 2012.
The following transactions have been made under the program:
|
Number of shares |
Average
purchase price |
Transaction value,
DKK |
Accumulated,
last announcement |
2,674,429 |
|
425,893,977 |
June 8, 2012 |
15,000 |
156.89 |
2,353,338 |
June 11, 2012 |
35,000 |
161.98 |
5,669,317 |
June 12, 2012 |
30,000 |
160.86 |
4,825,806 |
June 13, 2012 |
20,668 |
160.89 |
3,325,279 |
June 14, 2012
|
37,996 |
159.77 |
6,070,618 |
Accumulated
under the program |
2,813,093 |
|
448,138,335 |
Transactions related to Novozymes’ incentive programs have resulted in a net sale by Novozymes of 33,308 B shares in the period from June 8, to June 14, 2012. The shares related to these transactions were not part of the Safe Harbour share buyback program.
With the transactions stated above, Novozymes owns a total of 10,705,534 treasury shares, corresponding to 3.3% of the share capital. The total amount of shares in the company is 325,000,000 including treasury shares.
Contact persons:
Press and media: |
Investor relations: |
René Tronborg (Europe)
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274
Paige Donnelly (USA)
Tel. (direct): +1 919 494 3209
Tel. (mobile): +1 919 218 4501 |
Martin Riise
Tel. (direct): +45 4446 0738
Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3483
Tel. (mobile): +1 919 649 2565 |